WASHINGTON -- Parents and advocates are meeting on Capitol Hill to ask the nation's leaders and pharmaceutical companies to stop using the mercury preservative thimerosal in all vaccines, to inform Americans about vaccines with mercury, and to recall existing thimerosal stocks from health care facilities. Mercury is a known neurotoxin and has been linked to brain disorders including autism, Alzheimer's and other chronic neurological dysfunction.
"Why are vaccine makers still using thimerosal and unnecessarily exposing infants, pregnant women and unsuspecting Americans -- including members of Congress -- to mercury?" asked Michael Bender, director of the Mercury Policy Project. "Vaccines are supposed to help prevent health problems and not create them. Continued use of mercury in medical products for any human use, where avoidable, is simply irresponsible and not worth the risk."
U.S. health and governmental officials seem to agree. In 1982, a Food and Drug Administration (FDA) expert panel recommended that mercury be eliminated from over-the-counter health products. In 1999, the FDA and the American Academy of Pediatrics (AAP) urged manufacturers to remove thimerosal from childhood vaccines. In 2001, the Institute of Medicine recommended that children and pregnant women avoid thimerosal whenever possible.
While today, most, but not all, infant vaccines are mercury-free. The preservative is still added to formulations for influenza, diphtheria-tetanus, tetanus, hepatitis B, pneumococcal and rabies. This year the Centers for Disease Control and Prevention (CDC) recommended for the first time that healthy children receive influenza vaccine. No influenza vaccines are available that are completely mercury-free, although two brands only contain trace amounts.
"During the past decade children were given many more vaccines containing mercury, and the rate of autism skyrocketed. Mercury can cause the same symptoms and abnormalities we see in autism. Like lead exposures, there is no "safe" level for mercury," said Sallie Bernard, director of SAFE MINDS. "The removal of thimerosal from OTC products and most childhood vaccines shows this preservative is an absolutely unnecessary ingredient. We urge that U.S. policies be changed and that vaccines manufacturers completely and unequivocally refrain from using this deadly toxin without delay."
The U.S. health science panel that extensively reviewed thimerosal was unable to "either accept or reject a causal relationship" between autism and thimerosal, and stated that additional studies were needed. According to the Institute of Medicine's 2001 Immunization Safety Review Committee, "While the available scientific data do not establish that these neurodevelopmental disorders are caused by thimerosal, at the same time, they do not establish that these neurodevelopmental disorders are not caused by thimerosal. The hypothesis that exposure to thimerosal-containing vaccines could be associated with neuordevelopmental disorders was biologically plausible."
"Vaccine manufacturers have now been given protection from financial liability for mercury-related vaccine injuries in the Homeland Security Act so they don't have to worry about the harm it's caused to the brains of children and adults," said Barbara Loe Fisher, co-founder and president of the National Vaccine Information Center. "They may be off the hook financially but they are not off the hook morally. They should do the right thing and make all vaccines mercury-free.
To view the Center for Disease Controls list of influenza vaccines containing mercury, see: http://www.909shot.com/Issues/mercury.htm.
To view the manufacturers list of vaccines still containing mercury, see: http://www.vaccinesafety.edu/thi-table.htm.
More information is available at -
http://www.aap.org/advocacy/archives/julvacc.htm
http://www.iom.edu/IOM/IOMHome.nsf/Pages/thimerosal+report
http://www.safeminds.org/
http://www.mercurypolicy.org/
http://www.909shot.com/
Source: SAFEMINDS; Mercury Project
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.